Alfonso F, Pérez-Vizcayno MJ, García del Blanco B, Otaegui I, Masotti M, Zueco J, et al. Long-term results of Everolimus-Eluting stents Versus Drug-Eluting balloons in patients with Bare-Metal In-Stent restenosis. JACC Cardiovasc Interv. 2016;9:1246–55. https://doi.org/10.1016/j.jcin.2016.03.037.

Article  PubMed  Google Scholar 

Habara S, Iwabuchi M, Inoue N, Nakamura S, Asano R, Nanto S, et al. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Am Heart J. 2013;166:527–e5332. https://doi.org/10.1016/j.ahj.2013.07.002.

Article  CAS  PubMed  Google Scholar 

Jensen CJ, Richardt G, Tölg R, Erglis A, Skurk C, Jung W, et al. Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX randomised controlled trial. EuroIntervention. 2018;14:1096–103. https://doi.org/10.4244/EIJ-D-17-01079.

Article  PubMed  Google Scholar 

Baan J, Claessen BE, Dijk KB, Vendrik J, van der Schaaf RJ, Meuwissen M, et al. A Randomized comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the treatment of any In-Stent restenosis. JACC Cardiovasc Interv. 2018;11:275–83. https://doi.org/10.1016/j.jcin.2017.10.024.

Article  PubMed  Google Scholar 

Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, Yamamoto H, et al. Effectiveness of Paclitaxel-Eluting Balloon catheter in patients with Sirolimus-Eluting Stent Restenosis. JACC Cardiovasc Interv. 2011;4:149–54. https://doi.org/10.1016/j.jcin.2010.10.012.

Article  PubMed  Google Scholar 

Byrne RA, Neumann F-J, Mehilli J, Pinieck S, Wolff B, Tiroch K, et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet. 2013;381:461–7. https://doi.org/10.1016/S0140-6736(12)61964-3.

Article  CAS  PubMed  Google Scholar 

Kufner S, Cassese S, Valeskini M, Neumann F-J, Schulz-Schüpke S, Hoppmann P, et al. Long-term efficacy and safety of Paclitaxel-Eluting balloon for the treatment of drug-eluting stent restenosis. JACC Cardiovasc Interv. 2015;8:877–84. https://doi.org/10.1016/j.jcin.2015.01.031.

Article  PubMed  Google Scholar 

Rittger H, Brachmann J, Sinha A-M, Waliszewski M, Ohlow M, Brugger A, et al. A Randomized, Multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with Plain Balloon Angioplasty in Drug-Eluting Stent Restenosis. J Am Coll Cardiol. 2012;59:1377–82. https://doi.org/10.1016/j.jacc.2012.01.015.

Article  CAS  PubMed  Google Scholar 

Abdelaziz A, Hafez A, Atta K, Elsayed H, Abdelaziz M, Elaraby A, et al. Drug-coated balloons versus drug-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention: an updated meta-analysis with trial sequential analysis. BMC Cardiovasc Disord. 2023;23(1):605. https://doi.org/10.1186/s12872-023-03633-w.

Wong YTA, Kang D-Y, Lee JB, Rha S-W, Hong YJ, Shin E-S, et al. Comparison of drug-eluting stents and drug-coated balloon for the treatment of drug-eluting coronary stent restenosis: a randomized RESTORE trial. Am Heart J. 2018;197:35–42. https://doi.org/10.1016/j.ahj.2017.11.008.

Article  CAS  PubMed  Google Scholar 

Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, García del Blanco B, García-Touchard A, López-Minguéz JR, et al. A prospective Randomized Trial of Drug-Eluting balloons Versus Everolimus-Eluting stents in patients with In-Stent restenosis of drug-eluting stents. J Am Coll Cardiol. 2015;66:23–33. https://doi.org/10.1016/j.jacc.2015.04.063.

Article  CAS  PubMed  Google Scholar 

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700–2700. https://doi.org/10.1136/bmj.b2700.

Article  PubMed  PubMed Central  Google Scholar 

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;l4898. https://doi.org/10.1136/bmj.l4898.

Adriaenssens T, Dens J, Ughi G, Bennett J, Dubois C, Sinnaeve P, et al. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a drug elUting balloon in coronary artery rEstenosis) randomised clinical trial. EuroIntervention. 2014;10:439–48. https://doi.org/10.4244/EIJV10I4A77.

Article  PubMed  Google Scholar 

Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, García del Blanco B, Seidelberger B, Iñiguez A, et al. A Randomized comparison of drug-eluting balloon Versus Everolimus-Eluting stent in patients with Bare-Metal Stent–In-Stent restenosis. J Am Coll Cardiol. 2014;63:1378–86. https://doi.org/10.1016/j.jacc.2013.12.006.

Article  CAS  PubMed  Google Scholar 

Pleva L, Kukla P, Kusnierova P, Zapletalova J, Hlinomaz O. Comparison of the efficacy of Paclitaxel-Eluting Balloon catheters and Everolimus-Eluting stents in the treatment of coronary In-Stent restenosis. Circ Cardiovasc Interv. 2016;9. https://doi.org/10.1161/CIRCINTERVENTIONS.115.003316.

Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, et al. Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the treatment of coronary In-Stent restenosis. Circulation. 2009;119:2986–94. https://doi.org/10.1161/CIRCULATIONAHA.108.839282.

Article  CAS  PubMed  Google Scholar 

Xu B, Gao R, Wang J, Yang Y, Chen S, Liu B, et al. A prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon Versus Paclitaxel-Eluting Stent for the treatment of drug-eluting stent In-Stent restenosis. JACC Cardiovasc Interv. 2014;7:204–11. https://doi.org/10.1016/j.jcin.2013.08.011.

Article  PubMed  Google Scholar 

Alfonso F, Pérez-Vizcayno MJ, Cuesta J, García del Blanco B, García-Touchard A, López-Mínguez JR, et al. 3-Year clinical Follow-Up of the RIBS IV Clinical Trial. JACC Cardiovasc Interv. 2018;11:981–91. https://doi.org/10.1016/j.jcin.2018.02.037.

Article  PubMed  Google Scholar 

Pleva L, Kukla P, Zapletalova J, Hlinomaz O. Long-term outcomes after treatment of bare-metal stent restenosis with paclitaxel-coated balloon catheters or everolimus-eluting stents: 3-year follow-up of the TIS clinical study. Catheter Cardiovasc Interv. 2018;92:E416–24. https://doi.org/10.1002/ccd.27688.

Article  PubMed  Google Scholar 

Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study. EuroIntervention. 2015;11:926–34. https://doi.org/10.4244/EIJY14M08_12.

Article  PubMed  Google Scholar 

Xu B, Qian J, Ge J, Wang J, Chen F, Chen J, et al. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: a prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis. Catheter Cardiovasc Interv. 2016;87:624–9. https://doi.org/10.1002/ccd.26401.

Article  PubMed  Google Scholar 

Muramatsu T, Kozuma K, Tanabe K, Morino Y, Ako J, Nakamura S, et al. Clinical expert consensus document on drug-coated balloon for coronary artery disease from the Japanese Association of Cardiovascular Intervention and therapeutics. Cardiovasc Interv Ther. 2023;38:166–76. https://doi.org/10.1007/s12928-023-00921-2.

Article  PubMed  PubMed Central  Google Scholar 

Buccheri D, Piraino D, Andolina G, Cortese B. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. J Thorac Dis. 2016;8:E1150–62. https://doi.org/10.21037/jtd.2016.10.93.

Article  PubMed  PubMed Central  Google Scholar 

Cui K-Y, Lyu S-Z, Zhang M, Song X-T, Yuan F, Xu F. Drug-eluting balloon versus New-Generation Drug-Eluting Stent for the treatment of In-Stent restenosis. Chin Med J (Engl). 2018;131:600–7. https://doi.org/10.4103/0366-6999.226073.

Article  PubMed  Google Scholar 

Gao S, Shen J, Mukku VK, Wang MJ, Akhtar M, Liu W. Efficacy of drug-eluting balloons for patients with In-Stent restenosis. Angiology. 2016;67:612–21. https://doi.org/10.1177/0003319715611826.

Article  CAS  PubMed  Google Scholar 

Peng N, Liu W, Li Z, Wei J, Chen X, Wang W, et al. Drug-coated balloons versus Everolimus-Eluting stents in patients with In-Stent restenosis: a pair-wise Meta-analysis of Randomized trials. Cardiovasc Ther. 2020;2020:1–11. https://doi.org/10.1155/2020/1042329.

Article  CAS  Google Scholar 

Byrne RA, Joner M, Alfonso F, Kastrati A. Drug-coated balloon therapy in coronary and peripheral artery disease. Nat Rev Cardiol. 2014;11:13–23. https://doi.org/10.1038/nrcardio.2013.165.

Article  CAS  PubMed  Google Scholar 

Ullrich H, Olschewski M, Münzel T, Gori T. Coronary In-Stent restenosis: predictors and treatment. Dtsch Arztebl Int. 2021. https://doi.org/10.3238/arztebl.m2021.0254.

Article  PubMed  PubMed Central  Google Scholar 

Shlofmitz E, Iantorno M, Waksman R. Restenosis of drug-eluting stents. Circ Cardiovasc Interv. 2019;12. https://doi.org/10.1161/CIRCINTERVENTIONS.118.007023.

Pleva L, Kukla P, Hlinomaz O. Treatment of coronary in-stent restenosis: a systematic review. J Geriatr Cardiol. 2018;15:173–84. https://doi.org/10.11909/j.issn.1671-5411.2018.02.007